Loss of Regulator of G Protein Signaling 11 Promotes Protumorigenic Features in Pancreatic Cancer
RGS11 identified as a downstream target of a gemcitabine transporter CNT1 exerts potent antitumorigenic features in PDAC with therapeutic and prognostic values.
Authors
- Tejinder Kaur (ORCID: https://orcid.org/0000-0002-5200-7461)
- Amy Webb (ORCID: https://orcid.org/0000-0001-5503-7300)
- Rajgopal Govindarajan (ORCID: https://orcid.org/0000-0002-2958-5773)
- Junan Li (ORCID: https://orcid.org/0000-0003-0381-9356)
- Arnav Joshi (ORCID: https://orcid.org/0000-0002-2719-2247)
- Debasis Nayak (ORCID: https://orcid.org/0000-0002-0602-4367)
Institutions
- The Ohio State University (US)
Publication Details
- Journal
- Molecular Cancer Research
- Published
- 2025-10-14
- DOI
- https://doi.org/10.1158/1541-7786.mcr-25-0144
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00